Endocannabinoids and related fatty acid derivatives in pain modulation (Q34167541)

31 July 2017

1 reference

title

Endocannabinoids and related fatty acid derivatives in pain modulation (English)

1 reference

31 July 2017

0 references

0 references

J Michael Walker

1

1 reference

31 July 2017

Jocelyn F Krey

series ordinal

2

1 reference

31 July 2017

Constance J Chu

series ordinal

3

1 reference

31 July 2017

Susan M Huang

series ordinal

4

1 reference

31 July 2017

publication date

1 December 2002

1 reference

Chemistry and Physics of Lipids

31 July 2017

published in

1 reference

31 July 2017

volume

121

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

159-172

1 reference

The effects of cannabinoids on the brain

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Oxidative metabolism of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Regulation of anandamide tissue levels by N-arachidonylglycine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Control of pain initiation by endogenous cannabinoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Chemical characterization of a family of brain lipids that induce sleep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Analgesic and antiinflammatory activity of constituents of Cannabis sativa L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

The Sleep-inducing Lipid Oleamide Deconvolutes Gap Junction Communication and Calcium Wave Transmission in Glial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

The analgesic effects of R( )-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Cannabinoid receptors undergo axonal flow in sensory nerves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

A pharmacological analysis of levonantradol antinociception in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Antipyretic, analgesic and anti-inflammatory effects of delta 9-tetrahydrocannabinol in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Psychological and Physiological Mechanisms of Pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Anandamide may mediate sleep induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Antihyperalgesic effects of spinal cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Pain modulation by release of the endogenous cannabinoid anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0009-3084(02)00152-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-3084(02)00152-4

1 reference

31 July 2017

1 reference